TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2405171

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (total mean dose of 54 Gy to the breast)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Surgery alone (no further treatment)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 381

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 381
Study: 415321

Group type: EXPERIMENTAL
Intervention: Marijuana (0.7 mg/kg delta‐9‐tetrahydrocannabinol)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethanol (1.0 ml/kg 95% ethanol)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31638330

Group type: EXPERIMENTAL
Intervention: hsTnT measurements in patients with normal baseline hsTnT values (N = 357)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: hsTnT measurements in patients with elevated baseline hsTnT values (N = 173)
Number of subjects: 530
Study: 30165156

Group type: EXPERIMENTAL
Intervention: 80% reduction of basal insulin applied 40 minutes before exercise (T-40)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 80% reduction of basal insulin applied 20 minutes before exercise (T-20)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 80% reduction of basal insulin applied at exercise onset (T0)
Number of subjects: 22
Study: 28931236

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP) with primaquine (PQ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 0
Study: 25766513

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV)
Number of subjects: 66
Study: 23466100

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg and 40 mg
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 21771987

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus triptorelin (3.75 mg intramuscularly at least 1 week before chemotherapy and then every 4 weeks during chemotherapy)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 281
Study: 19002689

Group type: EXPERIMENTAL
Intervention: Studer pouch
Number of subjects: 462

Group type: COMPARATOR
Intervention: T-pouch
Number of subjects: 462
Study: 16766776

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (12 g of BCAAs/day; leucine 54%, isoleucine 19%, valine 27%)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (12 g of glucose/day)
Number of subjects: 19
Study: 15634480

Group type: EXPERIMENTAL
Intervention: LASIK surgery with residual corneal stroma bed thickness
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: LASIK surgery with residual corneal stroma bed thickness > 300 microm
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Postoperative measurement of posterior curvature of cornea
Number of subjects: 227
Study: 10760641

Group type: EXPERIMENTAL
Intervention: UK IBDQ
Number of subjects: 180
Study: 9250944

Group type: EXPERIMENTAL
Intervention: Ketamine psychedelic therapy (KPT)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 211
Study: 8222534

Group type: EXPERIMENTAL
Intervention: PGE1 infusion (20-30 ng kg-1 min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 20
Study: 3929876

Group type: EXPERIMENTAL
Intervention: Feverfew capsules (freeze dried powder)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31337448

Group type: EXPERIMENTAL
Intervention: Protein supplementation (27.5 g whey protein/d, about 2000 kJ/d)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Isoenergetic placebo-products (< 1.5 g protein/d)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Both groups (Protein and Placebo)
Number of subjects: 165
Study: 30430861

Group type: EXPERIMENTAL
Intervention: Full contingency table with causal explanation
Number of subjects: 245

Group type: COMPARATOR
Intervention: Basic refutation of multivitamin efficacy
Number of subjects: 245
Study: 26693964

Group type: EXPERIMENTAL
Intervention: STAR intervention (Supporting Treatment Adherence Regimens)
Number of subjects: 50

Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 50
Study: 24682210

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 85
Study: 22198375

Group type: EXPERIMENTAL
Intervention: 4 nights of sleep restriction (9, 8, 7, 6, or 5 h time in bed)
Number of subjects: 88

Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (6 h time in bed)
Number of subjects: 88

Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (5 h time in bed)
Number of subjects: 88

Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (7 h time in bed)
Number of subjects: 88

Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (8 h time in bed)
Number of subjects: 88

Group type: COMPARATOR
Intervention: 4 nights of sleep restriction (9 h time in bed)
Number of subjects: 88
Study: 20580358

Group type: EXPERIMENTAL
Intervention: Recombinant hCG (250 μg)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Urinary-derived hCG (10,000 IU)
Number of subjects: 119
Study: 17673609

Group type: EXPERIMENTAL
Intervention: Fulvestrant (250 mg/month)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fulvestrant high-dose (500 mg/month)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fulvestrant loading-dose regimen (250 mg/month plus 500 mg on day 0 and 250 mg on day 14 of month 1)
Number of subjects: 0
Study: 16051400

Group type: EXPERIMENTAL
Intervention: Booster dose of pertussis vaccine
Number of subjects: 542

Group type: COMPARATOR
Intervention: Third dose of pertussis vaccine
Number of subjects: 542
Study: 11966926

Group type: EXPERIMENTAL
Intervention: Subgingival water irrigation 2x daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ultrasonic scaling and scaling and root planing (Control)
Number of subjects: 52
Study: 10080558

Group type: EXPERIMENTAL
Intervention: Fananserin 250 mg b.i.d. over 28 days (with an 8-day escalation)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 7593920

Group type: EXPERIMENTAL
Intervention: Masker in-phase and signal in-phase (NoSo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Masker in-phase and signal pi rad out-of-phase (NoS pi)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random-center-frequency condition (NoS pi)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gaussian noise masker
Number of subjects: 0

Group type: COMPARATOR
Intervention: Informational masker comprised of eight randomly chosen eight-tone bursts centered at 1000 Hz
Number of subjects: 0
Study: 1965456

Group type: EXPERIMENTAL
Intervention: Non-AIDS medical diagnosis
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: DNR orders
Number of subjects: 600

Group type: COMPARATOR
Intervention: AIDS-related risk factors (gay v. IVDU)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Medical diagnosis (AIDS v. non-AIDS)
Number of subjects: 600

Group type: COMPARATOR
Intervention: DNR order v. no DNR order
Number of subjects: 600
Study: 7018502

Group type: EXPERIMENTAL
Intervention: Colestipol (15, 20, and 30 g/day)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Clofibrate (2 g/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 30478597

Group type: EXPERIMENTAL
Intervention: Email method
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Telephone method
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Postal method
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Public hospitals
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Email compared to Telephone
Number of subjects: 1168
Study: 29231482

Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP 6) + Diji (SP 8)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP 6) + Zusanli (ST 36)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP 6) + Taichong (LR 3)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cervical blockage anesthesia with lidocaine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Blank group (without analgesia)
Number of subjects: 200
Study: 25605812

Group type: EXPERIMENTAL
Intervention: DIAMOS (Diabetes Motivation Strengthening)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control Group (CG) - diabetes education
Number of subjects: 214
Study: 23314693

Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) applied at the dorsolateral prefrontal cortex (DLPFC) bilaterally
Number of subjects: 50

Group type: COMPARATOR
Intervention: tACS (transcranial alternating current stimulation) applied at the dorsolateral prefrontal cortex (DLPFC) bilaterally
Number of subjects: 50
Study: 22423411

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment alone
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment combined with orthognathic surgery
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (orthodontic treatment alone)
Number of subjects: 34
Study: 19521294

Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 80
Study: 18378947

Group type: EXPERIMENTAL
Intervention: Chin-down posture (n = 259)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Nectar-thick liquids (n = 133)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Honey-thick liquids (n = 123)
Number of subjects: 515

Group type: COMPARATOR
Intervention: Thickened liquids (nectar or honey)
Number of subjects: 515

Group type: COMPARATOR
Intervention: Chin-down posture
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Thickened liquids
Number of subjects: 515
Study: 16287352

Group type: EXPERIMENTAL
Intervention: Group 1 (G1) - 6RM sets in set repetition format for 5 exercises
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group 2 (G2) - 6RM sets in set repetition format for 6 exercises
Number of subjects: 0
Study: 12297762

Group type: EXPERIMENTAL
Intervention: Somatostatin (750 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabexate (500 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10405838

Group type: EXPERIMENTAL
Intervention: Unhydrated Haemoccult II
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjects aged > or = 65
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cancers of the distal colon
Number of subjects: 0
Study: 7480761

Group type: EXPERIMENTAL
Intervention: TACE-PEI group (single TACE session followed by PEI)
Number of subjects: 53

Group type: COMPARATOR
Intervention: TACE group (two to five TACE sessions)
Number of subjects: 53
Study: 2148357

Group type: EXPERIMENTAL
Intervention: Fosinopril (5 to 40 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (22 controls and 17 uninephrectomized donors)
Number of subjects: 10
Study: 7305427

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 31996583

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 862

Group type: COMPARATOR
Intervention: Neoadjuvant chemoradiotherapy followed by total mesorectal excision
Number of subjects: 862
Study: 30747567

Group type: EXPERIMENTAL
Intervention: Tai Chi intervention (1 hour session, 2 times per week for 12 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study: 29931409

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg three times daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (FOLFOX-4 regimen only)
Number of subjects: 40
Study: 27608620

Group type: EXPERIMENTAL
Intervention: 10 weeks of physical training
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 10 weeks of cognitive training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Matched wait-list control condition
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Self-reported lifestyle activities
Number of subjects: 54
Study: 24274808

Group type: EXPERIMENTAL
Intervention: Tailored decision aid (DA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nontailored information about prostate cancer screening (control)
Number of subjects: 0
Study: 22424001

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention (experimental group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine practice (control group)
Number of subjects: 34
Study: 20428949

Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Prucalopride 4 mg
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg and 4 mg
Number of subjects: 196
Study: 18522689

Group type: EXPERIMENTAL
Intervention: modafinil 400 mg
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: dextroamphetamine 20 mg
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: caffeine 600 mg
Number of subjects: 53

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 53
Study: 16706812

Group type: EXPERIMENTAL
Intervention: Photic stimulation for 25 min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no photic stimulation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Photic stimulation
Number of subjects: 40
Study: 12943873

Group type: EXPERIMENTAL
Intervention: Gemcabene 150 mg
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Gemcabene 300 mg
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Gemcabene 600 mg
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Gemcabene 900 mg
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 10384232

Group type: EXPERIMENTAL
Intervention: Vehicle speed change and relative head restraint position
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seated posture measures
Number of subjects: 0
Study: 8763975

Group type: EXPERIMENTAL
Intervention: Diabetic subjects
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 28
Study: 1707149

Group type: EXPERIMENTAL
Intervention: Sucralfate suspension
Number of subjects: 14

Group type: COMPARATOR
Intervention: Diphenhydramine syrup plus kaolin-pectin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (retrospective review of 15 patients without mouth-coating rinse)
Number of subjects: 14
Study: 6809324

Group type: EXPERIMENTAL
Intervention: Intravenous hyperalimentation (IVH)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No intravenous hyperalimentation (Control group)
Number of subjects: 49
Study: 31617992

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam plus amikacin (Group A)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (Group B)
Number of subjects: 164
Study: 28641027

Group type: EXPERIMENTAL
Intervention: Theoretical-practical course in Spirituality and Health (S/H)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control Group (waiting list)
Number of subjects: 49
Study: 25725183

Group type: EXPERIMENTAL
Intervention: Oxybutynin 5mg, t.d.s.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tolterodine 2mg, b.i.d.
Number of subjects: 100
Study: 23311732

Group type: EXPERIMENTAL
Intervention: ACT-178882 300 mg single-dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACT-178882 300 or 600 mg multiple-dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT-178882 multiple-dose
Number of subjects: 0
Study: 21333466

Group type: EXPERIMENTAL
Intervention: Baclofen (80 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 19732431

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Small-incision cholecystectomy
Number of subjects: 0
Study: 17643781

Group type: EXPERIMENTAL
Intervention: Photoprotection of total parenteral nutrition (TPN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN) without photoprotection
Number of subjects: 0
Study: 15753144

Group type: EXPERIMENTAL
Intervention: 400 mg RRR‐alpha‐tocopheryl acetate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 400 mg all‐rac‐alpha‐tocopheryl acetate
Number of subjects: 24
Study: 11727359

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - 0.625 mg 17 beta‐estradiol plus 10 mg progestin, followed for 48 months
Number of subjects: 186

Group type: COMPARATOR
Intervention: No therapy (Control group)
Number of subjects: 186
Study: 9629815

Group type: EXPERIMENTAL
Intervention: Hospital-based smoking cessation intervention delivered by midwives during routine antenatal and postnatal care
Number of subjects: 220

Group type: COMPARATOR
Intervention: Usual care (historical control group)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Hospital-based smoking cessation intervention
Number of subjects: 220
Study: 8163135

Group type: EXPERIMENTAL
Intervention: Jumbo biopsy forceps
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard biopsy forceps
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Jumbo biopsy specimens oriented with stereomicroscopy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Jumbo biopsy specimens oriented with naked eye
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard biopsy specimens (irrespective of orientation)
Number of subjects: 18
Study: 3367677

Group type: EXPERIMENTAL
Intervention: Low-energy helium-neon (HeNe) laser irradiation (0.9 mW) for 60 seconds daily over a 5-day period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control cultures (not irradiated)
Number of subjects: 0
Study: 31236402

Group type: EXPERIMENTAL
Intervention: Catheter inserted into the anterior region of the TPVS (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Catheter inserted into the posterior region of the TPVS (group P)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 28260640

Group type: EXPERIMENTAL
Intervention: Intervention group (not specified)
Number of subjects: 762

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Women's acceptance of IPV
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Men's attitudes towards IPV
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Women's first report of IPV in Waves 2 or 3
Number of subjects: 762
Study: 26440227

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose (LD)/90 mg twice‐daily maintenance dose (MD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel 600 mg LD/75 mg once‐daily MD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 40
Study: 23121074

Group type: EXPERIMENTAL
Intervention: Counselling intervention (four face-to-face sessions and one telephone session)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (no counselling intervention)
Number of subjects: 219
Study: 22220459

Group type: EXPERIMENTAL
Intervention: Congenital glaucoma patients
Number of subjects: 27

Group type: COMPARATOR
Intervention: Antiglaucomatous operation
Number of subjects: 27
Study: 19185649

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg/d)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 17003097

Group type: EXPERIMENTAL
Intervention: Hypothyroid group (HO)
Number of subjects: 21
Study: 15250768

Group type: EXPERIMENTAL
Intervention: Optical transillumination spectroscopy
Number of subjects: 92
Study: 11206241

Group type: EXPERIMENTAL
Intervention: Skin test (ST) with a panel of aeroallergens plus tobacco extract
Number of subjects: 170
Study: 9522323

Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 2.5 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 5 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 10 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 17 beta‐estradiol, 2 mg orally per day, continuously combined with dydrogesterone 15 mg
Number of subjects: 123

Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 123

Group type: COMPARATOR
Intervention: Women in the highest quartile of bone turnover at baseline
Number of subjects: 123
Study: 7702336

Group type: EXPERIMENTAL
Intervention: Ioxaglate 320
Number of subjects: 38

Group type: COMPARATOR
Intervention: Iopromide 370
Number of subjects: 38
Study: 2889313

Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 3

Group type: COMPARATOR
Intervention: Internal intercostal nerve block
Number of subjects: 3

Group type: COMPARATOR
Intervention: No analgesia
Number of subjects: 3
Study: 29359385

Group type: EXPERIMENTAL
Intervention: Focused ultrasound device (UltraShape) treatment on one thigh
Number of subjects: 14
Study: 27013313

Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding at ≤1 hour
Number of subjects: 99632

Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding at 2-23 hours
Number of subjects: 99632

Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding at 24-96 hours
Number of subjects: 99632

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding at 1 month
Number of subjects: 99632
Study: 24678761

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention programme comprising three structured and individualised counselling sessions on a healthy diet, regular physical activity, and weight monitoring during pregnancy and one session after delivery.
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention programme
Number of subjects: 2500

Group type: COMPARATOR
Intervention: General recommendations for a healthy lifestyle (Control)
Number of subjects: 2500
Study: 24345027

Group type: EXPERIMENTAL
Intervention: Dietary intervention to reduce sodium intake
Number of subjects: 240
Study: 21038947

Group type: EXPERIMENTAL
Intervention: Worry
Number of subjects: 73

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Neutral thought activity
Number of subjects: 73
Study: 18412719

Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35